Tammy Li, OD
Optometrist · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 4 carriers
- Office
- 1
Offices
1 location
Plans that list them
9 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Li’s office at (415) 519-8288 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C33827 · Cancelled
Licence status: Cancelled · since 1971 · University of North Carolina at Chapel Hill.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$396 in 2023
Medicaid paid $396 for 173 billed services this clinician did in 2023, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 16 | $142 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 34 | $107 |
| Fitting of monofocal spectacles | 32 | $58 |
| DETERMINATION REFRACTIVE STATE | 57 | $50 |
| Frames, purchases | 34 | $38 |
| 2023 | 173 | 5 | 35 | $396 |
| 2021 | 162 | 5 | 27 | $582 |
| 2020 | 59 | 3 | 19 | $134 |
See the largest Medicaid services in earlier years
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 13 | $249 |
| DETERMINATION REFRACTIVE STATE | 71 | $108 |
| Fitting of monofocal spectacles | 37 | $97 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $71 |
| Frames, purchases | 27 | $58 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $71 |
| DETERMINATION REFRACTIVE STATE | 32 | $43 |
| Fitting of monofocal spectacles | 13 | $19 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 120 Part D prescriptions in 2020.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 120 | 41 | 0% (0) | 77% | $53,054 |
| 2019 | 885 | 203 | 0% (0) | 89% | $430,188 |
| 2018 | 707 | 237 | 0% (0) | 93% | $312,762 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 5 drugs
| Xiidra | 16 | $17,715 | $1,107 |
| Restasis | 15 | $12,629 | $842 |
| Alphagan P | 23 | $10,072 | $438 |
| Brimonidine | 16 | $5,566 | $348 |
| Latanoprost | 21 | $409 | $19 |
2019: 10 drugs
| Restasis | 274 | $198,364 | $724 |
| Xiidra | 176 | $99,438 | $565 |
| Alphagan P | 155 | $66,394 | $428 |
| Lumigan | 50 | $17,194 | $344 |
| Combigan | 41 | $15,200 | $371 |
| Brimonidine | 56 | $14,966 | $267 |
| Restasis Multidose | 14 | $11,303 | $807 |
| Latanoprost | 47 | $954 | $20 |
| Dorzolamide-Timolol | 12 | $220 | $18 |
| Timolol Maleate | 23 | $183 | $8 |
2018: 9 drugs
| Restasis | 246 | $144,832 | $589 |
| Xiidra | 82 | $43,435 | $530 |
| Alphagan P | 120 | $39,488 | $329 |
| Restasis Multidose | 44 | $34,116 | $775 |
| Brimonidine | 66 | $21,195 | $321 |
| Lumigan | 45 | $15,374 | $342 |
| Combigan | 31 | $10,334 | $333 |
| Latanoprost | 12 | $304 | $25 |
| Timolol Maleate | 15 | $117 | $8 |
Money from drug and device companies
$29 in 2025
| 2025 | 1 | 1 | None | $29 |
| 2023 | 1 | 1 | None | $60 |
| 2021 | 1 | 1 | None | $21 |
| 2020 | 1 | 1 | None | $17 |
| 2019 | 3 | 4 | None | $64 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Johnson & Johnson Vision Care | None | $29 | 1 payment
|
See the published payment
| Johnson & Johnson Vision Care | Meals · 2025-05-14 | None | $29 |
See earlier years (2023, 2021, 2020, 2019)
2023: $60
| Johnson & Johnson Vision Care | None | $60 | 1 payment
|
2021: $21
| CooperVision | Misight Contact Lens | $21 | 1 payment
|
2020: $17
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $64
| Bausch & Lomb a division of Bausch Health US | Prolensa | $29 | 2 payments
|
| Dompe US | Oxervate | $18 | 1 payment
|
| Shire North American Group | Xiidra | $17 | 1 payment
|
Professional record
- NPI
- 1992214449
- Licence
- CA 33827California C33827: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 466 Northlake Dr Apt 1, San Jose, CA, 95117
- NPI first listed
- 2017-09-27
- NPI last updated
- 2019-06-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 369 Castro St, Mountain View, CA, 94041